Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and in silico studies

References

• Goncalves GA, Spillere AR, das Neves GM, Kagami LP, von Poser GL, et al. Natural and synthetic coumarins as antileishmanial agents: a review. Eur J Med Chem. 2020;203:112514.
   PubMed Web of Science ®Google Scholar
• Bekhit AA, El-Agroudy E, Helmy A, Ibrahim TM, Shavandi A, et al. Leishmania treatment and prevention: natural and synthesized drugs. Eur J Med Chem. 2018;160:229–244.
   PubMed Web of Science ®Google Scholar
• Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, Messina JP, Balard Y, Bastien P, Pratlong F, et al. Global distribution maps of the leishmaniases. eLife. 2014;3:e02851.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Leishmaniasis. 2020. Available from: https://www.who.int/health-topics/leishmaniasis#tab=tab_1.
   Google Scholar
• Ogutu B. Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Expert Opin Pharmacother. 2013;14:643–654.
   PubMed Web of Science ®Google Scholar
• Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941–955.
   PubMed Web of Science ®Google Scholar
• Rajasekaran R, Chen YP. Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs. Drug Discov Today. 2015;20:958–968.
   PubMed Web of Science ®Google Scholar
• Vickers TJ, Beverley SM. Folate metabolic pathways in Leishmania. Essays Biochem. 2011;51:63–80.
   PubMed Web of Science ®Google Scholar
• Nare B, Hardy LW, Beverley SM. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J Biol Chem. 1997;272:13883–13891.
   PubMed Web of Science ®Google Scholar
• Corona P, Gibellini F, Cavalli A, Saxena P, Carta A, et al. Structure-based selectivity optimization of piperidine–pteridine derivatives as potent Leishmania pteridine reductase inhibitors. J Med Chem. 2012;55:8318–8329.
   PubMed Web of Science ®Google Scholar
• Dube D, Periwal V, Kumar M, Sharma S, Singh TP, et al. 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors. J Mol Model. 2012;18:1701–1711.
   PubMed Web of Science ®Google Scholar
• de Souza Moreira D, Ferreira RF, Murta SMF. Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines. Exp Parasitol. 2016;160:60–66.
   PubMed Web of Science ®Google Scholar
• Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem. 2014;57:10257–10274.
   PubMed Web of Science ®Google Scholar
• Bailey PD, Smith PD, Morgan KM, Rosair GM. The use of the aza-Diels–Alder reaction in the synthesis of pinidine and other piperidine alkaloids. Tetrahedron Lett . 2002;43(6):1071–1074.
   Web of Science ®Google Scholar
• Amat M, Llor N, Hidalgo J, Escolano C, Bosch J. Enantioselective synthesis of piperidine, indolizidine, and quinolizidine alkaloids from a phenylglycinol-derived δ-lactam. J Org Chem. 2003;68:1919–1928.
   PubMed Web of Science ®Google Scholar
• Tortolani DR, Poss MA. A convenient synthesis to N-aryl-substituted 4-piperidones. Org Lett. 1999;1(8):1261–1262.
   Web of Science ®Google Scholar
• Weintraub PM, Sabol JS, Kane JM, Borcherding DR. Recent advances in the synthesis of piperidones and piperidines. Tetrahedron. 2003;59(17):2953–2989.
   Web of Science ®Google Scholar
• Jagt RBC, de Vries JG, Feringa BL, Minnaard AJ. Enantioselective synthesis of 2-aryl-4-piperidones via rhodium/phosphoramidite-catalyzed conjugate addition of arylboroxines. Org Lett. 2005;7(12):2433–2435.
   PubMed Web of Science ®Google Scholar
• Cong W, Sun Y, Sun Y-F, Yan W-B, Zhang Y-L, Gao Z-F, Wang C-H, Hou G-G, Zhang J-J. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation. J Enzyme Inhib Med Chem. 2021;36(1):1621–1630.
   Google Scholar
• Ganellin CR, Spickett RGW. Compounds affecting the central nervous system. I. 4-Piperidones and related compounds. J Med Chem. 1965;8(5):619–625.
   PubMed Web of Science ®Google Scholar
• Baracu I, Dobre V, Niculescu-Duvaz I. Potential anticancer agents. XXVI. Spin labelled nitrosoureas. J Prakt Chem. 1985;327(4):667–674.
   Google Scholar
• Meyers MJ, Anderson EJ, McNitt SA, Krenning TM, Singh M, Xu J, Zeng W, Qin L, Xu W, Zhao S, et al. Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents. Bioorg Med Chem. 2015;23(16):5144–5150.
   PubMed Web of Science ®Google Scholar
• Veale CGL. Unpacking the pathogen box—an open source tool for fighting neglected tropical disease. Chem Med Chem. 2019;14(4):386–453.
   Google Scholar
• Battista T, Colotti G, Ilari A, Fiorillo A. Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases. Molecules. 2020;25(8):1924.
   PubMed Web of Science ®Google Scholar
• Scala A, Cordaro M, Grassi G, Piperno A, Barberi G, Cascio A, Risitano F. Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity. Bioorg Med Chem. 2014;22(3):1063–1069.
   PubMed Web of Science ®Google Scholar
• Saha S, Acharya C, Pal U, Chowdhury SR, Sarkar K, Maiti NC, Jaisankar P, Majumder HK. A novel spirooxindole derivative inhibits the growth of Leishmania donovani parasites both in vitro and in vivo by targeting type IB topoisomerase. Antimicrob Agents Chemother. 2016;60(10):6281–6293.
   PubMed Web of Science ®Google Scholar
• Almeida FS, Sousa GLS, Rocha JC, Ribeiro FF, de Oliveira MR, de Lima Grisi TCS, Araújo DAM, de C Nobre MS, Castro RN, Amaral IPG, et al. In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum. Bioorg Med Chem Lett. 2021;49:128289.
   PubMed Web of Science ®Google Scholar
• Welton T. Room-temperature ionic liquids. Solvents for synthesis and catalysis. Chem Rev. 1999;99(8):2071–2084.
   PubMed Web of Science ®Google Scholar
• Mohamed MAA, Moustafa HM, El‐Remaily M. An efficient synthesis of some new azaspirocycloalkane derivatives from 1-anilinocycloalkanecarboxamide. Chem Sci. 2014;5:1–6.
   Google Scholar
• Mendoza-Martínez C, Galindo-Sevilla N, Correa-Basurto J, Ugalde-Saldivar VM, Rodríguez-Delgado RG, Hernández-Pineda J, Padierna-Mota C, Flores-Alamo M, Hernández-Luis F. Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies. Eur J Med Chem. 2015;92:314–331.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Gabriele E, Piazza F, Basilico N, Parapini S, Tasso B, Loddo R, Sparatore F, Sparatore A. Benzimidazole derivatives endowed with potent antileishmanial activity. J Enzyme Inhib Med Chem. 2018;33(1):210–226.
   PubMed Web of Science ®Google Scholar
• Arba M, Wahyudi ST, Brunt DJ, Paradis N, Wu C. Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2. Comput Biol Med. 2021;129:104156.
   PubMed Web of Science ®Google Scholar
• Ismail MI, Ragab HM, Bekhit AA, Ibrahim TM. Targeting multiple conformations of SARS-CoV2 papain-like protease for drug repositioning: an in-silico study. Comput Biol Med. 2021;131:104295.
   PubMed Web of Science ®Google Scholar
• Gordi Z, Eshghi H. Natural kaolin supported sulfuric acid as an efficient catalyst for selective hydrolysis of nitriles to amides. J Korean Chem Soc. 2011;55(4):715–718.
   Google Scholar
• Temraz MG, Elzahhar PA, Din A, Bekhit EA, Bekhit AA, Labib HF. Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies. Eur J Med Chem. 2018;151:585–600.
   PubMed Web of Science ®Google Scholar
• Bekhit AA, Lodebo ET, Hymete A, Ragab HM, Bekhit SA, Amagase K, Batubara A, Abourehab MAS, Bekhit AE-DA, Ibrahim TM, et al. New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations. J Enzyme Inhib Med Chem. 2022;37(1):2320–2333.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Almahli H, Ibrahim TM, Fares M, Al-Warhi T, Boeckler FM, Bekhit AA, Abdel-Aziz HA. Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio) semicarbazides as a novel class of anti-leishmanial agents. Eur J Med Chem. 2019;179:335–346.
   PubMed Web of Science ®Google Scholar
• Schüttelkopf AW, Hardy LW, Beverley SM, Hunter WN. Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design. J Mol Biol. 2005;352(1):105–116.
   PubMed Web of Science ®Google Scholar
• Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model. 1999;17(1):57–61.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
   PubMed Web of Science ®Google Scholar
• O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:33.
   PubMed Web of Science ®Google Scholar
• Elghoneimy LK, Ismail MI, Boeckler FM, Azzazy HME, Ibrahim TM. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking. Comput Biol Med. 2021;134:104468.
   PubMed Web of Science ®Google Scholar
• Bekhit AA, Nasralla SN, El-Agroudy EJ, Hamouda N, El-Fattah AA, Bekhit SA, Amagase K, Ibrahim TM. Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative. Eur J Pharm Sci. 2022;168:106080.
   PubMed Web of Science ®Google Scholar
• Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25.
   Google Scholar
• Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A. 2001;105(43):9954–9960.
   Web of Science ®Google Scholar
• Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126(1):014101.
   PubMed Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81(8):3684–3690.
   Web of Science ®Google Scholar
• Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52(12):7182–7190.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98(12):10089–10092.
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463–1472.
   Web of Science ®Google Scholar
• Huang J, MacKerell AD Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem. 2013;34(25):2135–2145.
   PubMed Web of Science ®Google Scholar
• Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011;32(11):2359–2368.
   PubMed Web of Science ®Google Scholar
• Turner P. XMGRACE, version 5.1. 19. Beaverton (OR): Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology; 2005.
   Google Scholar